Related Experiment Video
Updated: Jun 12, 2026

Evaluation of Antimicrobial Activities of Nanoparticles and Nanostructured Surfaces In Vitro
Published on: April 21, 2023
Inhibition of methicillin-resistant Staphylococcus aureus by the compound Qingre granules
Yi-yun Yu1, Hong Wang, Shu-wen Zhang
1Department of Infectious Diseases, Beijing Friendship Hospital, Capital Medical University, China.
Background:
The infection rate of methicillin-resistant Staphylococcus aureus (MRSA) is increasing yearly due to the overprescription of antibiotics. Traditional Chinese compound medicines are less inclined to induce bacterial resistance in the clinical setting because of their multi-acting mechanisms. However, most current research is limited to bacteriostasis in vitro using single extracts or formulations. Plasma pharmacology is an in vitro method, using what is called "medicine serum". The aim of this study was to investigate whether the medicine serum of compound Qingre granules (QRKL) alone or in combination with antibiotics may treat MRSA infection in the clinic.
Methods:
An animal model of MRSA resistance was created by injecting rabbits with the standard strain of MRSA ATCC43300. Infected rabbits were treated with QRKL by intragastric administration. Sixty minutes after the last intragastric administration, serum was obtained from the rabbits by heart puncture to obtain what is termed "medicine serum". The minimum inhibitory concentration (MIC) of QRKL, medicine serum alone, or serum combined with antibiotics was assessed by agar dilution.
Results:
were compared with the growth of sixteen isolates of MRSA.
Results:
The MIC of QRKL to the standard strain ATCC43300 was 10.00 mg/ml. The MIC(90) of vancomycin was 1.00 microg/ml, which, when combined with QRKL, dropped to 0.50 microg/ml. The MIC(90) of cefuroxime alone was 512.00 microg/ml. This level also decreased to 256.00 microg/ml when combined with QRKL. The addition of QRKL thus significantly reduced the MIC of both cefuroxime and vancomycin compared with antibiotics alone (P < 0.01). The MIC(90) of vancomycin with medicine serum decreased to 0.50 microg/ml, and the MIC of vancomycin with medicine serum also descended compared with using vancomycin alone (P < 0.01).
Conclusions:
The growth of MRSA can be inhibited by QRKL or medicine serum of QRKL in vitro. The addition of QRKL results in increased sensitivity of MRSA to vancomycin and this may provide a novel treatment for patients with MRSA infection.
Insights
Compound Qingre granules (QRKL) and its derived medicine serum show potential in inhibiting methicillin-resistant Staphylococcus aureus (MRSA) growth. Combining QRKL with antibiotics enhances MRSA sensitivity, offering a novel treatment approach for MRSA infections.
Area of Science:
- Pharmacology
- Microbiology
- Traditional Chinese Medicine
Background:
- Increasing rates of methicillin-resistant Staphylococcus aureus (MRSA) infections are driven by antibiotic overuse.
- Traditional Chinese compound medicines offer multi-acting mechanisms, potentially reducing bacterial resistance.
- Current research on these medicines often focuses on in vitro bacteriostasis using single extracts.
Purpose of the Study:
- To investigate the efficacy of compound Qingre granules (QRKL) medicine serum against MRSA.
- To evaluate the combined effect of QRKL medicine serum and antibiotics on MRSA.
- To explore a novel therapeutic strategy for MRSA infections.
Main Methods:
- An animal model of MRSA infection was established in rabbits.
- QRKL was administered intragastrically, and "medicine serum" was collected.
- Minimum inhibitory concentrations (MICs) of QRKL, medicine serum, and combinations with antibiotics were determined using agar dilution.
Main Results:
- QRKL demonstrated inhibitory effects against MRSA in vitro.
- Combining QRKL with vancomycin or cefuroxime significantly reduced their MICs compared to antibiotics alone (P < 0.01).
- Vancomycin combined with QRKL medicine serum showed a reduced MIC(90) to 0.50 microg/ml.
Conclusions:
- QRKL and its medicine serum can inhibit MRSA growth in vitro.
- QRKL enhances MRSA sensitivity to vancomycin, suggesting a potential new treatment.
- This study provides a basis for novel therapeutic strategies against MRSA infections.
Related Concept Videos
Clinical Significance of Antibiotic Resistance
Mechanism of Antibiotic Resistance in MRSA
Gene Regulation in Microbial Communities: Quorum Sensing
Inhibitors of Bacterial Protein Synthesis
Inhibitors of Gram-positive Cell Wall Synthesis
Antimicrobial Proteins
Interferons
Interferons (IFNs) are proteins produced by lymphocytes, macrophages, and fibroblasts infected with viruses. While IFNs cannot prevent viruses from entering and...

